MFS
ADPT icon

Mirabella Financial Services’s Adaptive Biotechnologies ADPT Stock Holding History

Mirabella Financial Services’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$236K Sell
10,999
-369
-3% -$5.65K 0.02% 561
2026
Q1 		$158K Buy
+11,368
New +$181K 0.01% 811
2022
Q3 		– Sell
-92,230
Closed -$746K – 320
2022
Q2 		$746K Buy
+92,230
New +$811K 0.07% 191

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Mirabella Financial Services's ADPT Position: Q2 2026 in Review

Mirabella Financial Services reduced its Adaptive Biotechnologies (ADPT) stake by 3.2% in Q2 2026, selling an estimated $5.65K and leaving 10,999 shares worth $236K. The position accounts for 0.02% of the portfolio, ranked #561.

Mirabella Financial Services first reported a position in ADPT in Q2 2022 and has held it in 3 quarters since. The position peaked at $746K in Q2 2022. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Mirabella Financial Services held 10,999 shares of Adaptive Biotechnologies worth $236K as of Q2 2026.
  • Mirabella Financial Services sold 369 Adaptive Biotechnologies shares in Q2 2026, an estimated $5.65K.
  • Adaptive Biotechnologies made up 0.02% of Mirabella Financial Services's portfolio in Q2 2026, its #561 holding.
  • Mirabella Financial Services first reported a position in Adaptive Biotechnologies in Q2 2022 and has held it in 3 quarters since.
  • Mirabella Financial Services's Adaptive Biotechnologies position peaked at $746K in Q2 2022.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.